These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18468743)

  • 41. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
    Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
    Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal and systemic SIV-specific cytotoxic CD4
    Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
    Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
    Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
    Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.
    Martins MA; Tully DC; Cruz MA; Power KA; Veloso de Santana MG; Bean DJ; Ogilvie CB; Gadgil R; Lima NS; Magnani DM; Ejima K; Allison DB; Piatak M; Altman JD; Parks CL; Rakasz EG; Capuano S; Galler R; Bonaldo MC; Lifson JD; Allen TM; Watkins DI
    J Virol; 2015 Nov; 89(21):10802-20. PubMed ID: 26292326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic vaccine-mediated Gag-specific CD8
    Nakamura-Hoshi M; Takahara Y; Matsuoka S; Ishii H; Seki S; Nomura T; Yamamoto H; Sakawaki H; Miura T; Tokusumi T; Shu T; Matano T
    Sci Rep; 2020 Jul; 10(1):11394. PubMed ID: 32647227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization.
    von Gegerfelt AS; Rosati M; Alicea C; Valentin A; Roth P; Bear J; Franchini G; Albert PS; Bischofberger N; Boyer JD; Weiner DB; Markham P; Israel ZR; Eldridge JH; Pavlakis GN; Felber BK
    J Virol; 2007 Feb; 81(4):1972-9. PubMed ID: 17135321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques.
    Hryniewicz A; Price DA; Moniuszko M; Boasso A; Edghill-Spano Y; West SM; Venzon D; Vaccari M; Tsai WP; Tryniszewska E; Nacsa J; Villinger F; Ansari AA; Trindade CJ; Morre M; Brooks D; Arlen P; Brown HJ; Kitchen CM; Zack JA; Douek DC; Shearer GM; Lewis MG; Koup RA; Franchini G
    J Immunol; 2007 Mar; 178(6):3492-504. PubMed ID: 17339444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
    Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
    J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.
    Patel V; Valentin A; Kulkarni V; Rosati M; Bergamaschi C; Jalah R; Alicea C; Minang JT; Trivett MT; Ohlen C; Zhao J; Robert-Guroff M; Khan AS; Draghia-Akli R; Felber BK; Pavlakis GN
    Vaccine; 2010 Jul; 28(30):4827-36. PubMed ID: 20451642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
    Virnik K; Rosati M; Medvedev A; Scanlan A; Walsh G; Dayton F; Broderick KE; Lewis M; Bryson Y; Lifson JD; Ruprecht RM; Felber BK; Berkower I
    PLoS One; 2020; 15(3):e0228163. PubMed ID: 32130229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.
    Kaur A; Sanford HB; Garry D; Lang S; Klumpp SA; Watanabe D; Bronson RT; Lifson JD; Rosati M; Pavlakis GN; Felber BK; Knipe DM; Desrosiers RC
    Virology; 2007 Jan; 357(2):199-214. PubMed ID: 16962628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
    Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
    J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrasting effects of low-dose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251.
    Nacsa J; Edghill-Smith Y; Tsai WP; Venzon D; Tryniszewska E; Hryniewicz A; Moniuszko M; Kinter A; Smith KA; Franchini G
    J Immunol; 2005 Feb; 174(4):1913-21. PubMed ID: 15699118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.
    Tryniszewska E; Nacsa J; Lewis MG; Silvera P; Montefiori D; Venzon D; Hel Z; Parks RW; Moniuszko M; Tartaglia J; Smith KA; Franchini G
    J Immunol; 2002 Nov; 169(9):5347-57. PubMed ID: 12391256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.